Additionally, Chen et al. have demonstrated that the PI3K/AKT/mTOR pathway is capable of regulating the effects of CEP55 on the migration, invasion and EMT of RCC cells and might be used as an effective prognostic marker [25]. The gene discussed is MTOR; the disease is renal cell carcinoma.